Skip to main content

Peer Review reports

From: Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma

Original Submission
13 Jan 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
3 Mar 2021 Reviewed Reviewer Report
11 Mar 2021 Reviewed Reviewer Report
17 Apr 2021 Author responded Author comments - Gang Jin
Resubmission - Version 4
17 Apr 2021 Submitted Manuscript version 4
21 Apr 2021 Author responded Author comments - Gang Jin
Resubmission - Version 5
21 Apr 2021 Submitted Manuscript version 5
22 Apr 2021 Author responded Author comments - Gang Jin
Resubmission - Version 6
22 Apr 2021 Submitted Manuscript version 6
23 Apr 2021 Author responded Author comments - Gang Jin
Resubmission - Version 7
23 Apr 2021 Submitted Manuscript version 7
23 Apr 2021 Reviewed Reviewer Report
23 Apr 2021 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
27 Apr 2021 Editorially accepted
26 May 2021 Article published 10.1186/s12885-021-08380-9

You can find further information about peer review here.

Back to article page